Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the long-term safety and tolerability of pregabalin in pediatric
patients, age 1 month through 16 years, with partial onset seizures.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.